<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04343066</url>
  </required_header>
  <id_info>
    <org_study_id>FMD195</org_study_id>
    <nct_id>NCT04343066</nct_id>
  </id_info>
  <brief_title>Bone Remodeling Around Implants With Two Different Surfaces Placed in Horizontally Augmented Bone</brief_title>
  <official_title>Clinical and Radiographic Evaluation of Bone Remodeling Around Implants With Two Different Surfaces Placed in Horizontally Augmented Bone: a 1-year Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Saint-Joseph University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Saint-Joseph University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this prospective controlled clinical trial is to evaluate the clinical and
      radiographical outcomes of two implant surfaces inserted in a crest that has been
      horizontally augmented at least 6 months prior to the implant placement. The horizontal GBR
      should be done with a xenogenic graft mixed with autologous bone particles, and a collagen
      membrane stabilized using tacks or screws.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, randomized clinical and radiographical evaluation of bone remodeling
      around implants with two different surfaces placed in a previously augmented crest.

      Patients requiring dental implants in previously horizontally augmented bone crest are
      recruited at the Department of Periodon¬tics, Faculty of dental medicine, Saint-Joseph
      University, Beirut, and will be treated with either T3 (contemporary hybrid collar), tapered,
      ex-hex, CP4 or Full Osseotite, tapered, ex-hex, CP4.

      A total of 30 implants will be placed (15 per group). Random allocation of implant type per
      site will be done by the sealed envelope method.

      The implants will be placed using a one-stage surgical approach. A final crown will be placed
      (screw-retained on multiunit abutment) between 3 and 4 months post-implant placement.

      The patients will be followed-up at 6 months and 1 year. Only patients meeting
      inclusion/exclusion criteria and providing a dated and signed informed consent form will be
      enrolled in the study.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">April 15, 2019</start_date>
  <completion_date type="Anticipated">June 30, 2020</completion_date>
  <primary_completion_date type="Actual">November 30, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline of alveolar ridge thickness at 4 months</measure>
    <time_frame>During procedure and at 4 months</time_frame>
    <description>Peroperative surgical measurements of the alveolar ridge width at implant sites</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline of radiographic bone level on CBCT at 1 year post-op</measure>
    <time_frame>During procedure and at 1 year</time_frame>
    <description>CBCT for buccal bone thickness measurements of the bone crest width at the implant site.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline of radiographic bone level assessment at 1 year post-op, on periapical x-ray</measure>
    <time_frame>During procedure, at 4 months, at 6 months and 1 year</time_frame>
    <description>Radiographic measurements on standardized periapical radiograph of the bone dimensions, for interproximal bone remodeling, from the shoulder of the implant (reference point), to the coronal bone to implant contact</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline of bone plate thickness at 4 months</measure>
    <time_frame>During procedure and at 4 months</time_frame>
    <description>Peroperative buccal and lingual residual bone thickness following implant insertion</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Insertion torque</measure>
    <time_frame>During procedure</time_frame>
    <description>Manual torque insertion are registered at implant placement.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of Clinical parameters from baseline to 1 year post-op</measure>
    <time_frame>During procedure, at 6 months and at 1 year</time_frame>
    <description>FMBS, FMPS,</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of FMBS parameters from baseline to 1 year post-op</measure>
    <time_frame>During procedure, at 6 months and at 1 year</time_frame>
    <description>Change in full mouth bleeding score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of Keratinized tissue height from Baseline to 4 months</measure>
    <time_frame>During procedure and at 4 months</time_frame>
    <description>Measured using a 1.0-mm marked periodontal probe</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Histological analysis</measure>
    <time_frame>During procedure</time_frame>
    <description>Bone core taken with a 2mm trephine bur at the site of implant placement for non-demineralized histological assessment of regenerated bone quality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of FMPS parameters from baseline to 1 year post-op</measure>
    <time_frame>During procedure, at 6 months and at 1 year</time_frame>
    <description>Change in full mouth plaque score</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Dental Implantation</condition>
  <condition>Bone Remodeling</condition>
  <arm_group>
    <arm_group_label>External hex implant</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>External hexagone implant connection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Internal hex implant</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Internal implant connection</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Implant insertion</intervention_name>
    <description>In both groups, the implants will be placed using a two-stage surgical approach at the crestal level in previously horizontally augmented bony sites.
A final crown will be placed (screw-retained on multiunit abutment) between 3- and 4-months post-implant placement.
Random allocation of implant type per site will be done by the sealed envelope method.
Follow-up measurements will be done at 6 months and 1-year post-loading. The measurements are done by a blinded investigator. Before starting the study, the examiner will be trained in a calibration process.
Exam sheets are kept confidential and anonymous. Inclusion criteria are: patient aged 20 to 65, no systematic contraindication for implant surgery, smoking &lt; 10 cigarettes, previous horizontal bone augmentation, FMBS &lt;20% and FMPS &lt; 20%. Exclusion criteria are: general contraindication for implant surgery, pregnant/lactating women, uncontrolled diabetics, patients not willing to sign the consent form, active periodontitis.</description>
    <arm_group_label>External hex implant</arm_group_label>
    <arm_group_label>Internal hex implant</arm_group_label>
    <other_name>Radiological bone level</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient age: between 20 and 65

          -  No systematic contraindication for implant surgery

          -  No more than 10 cigarettes/day

          -  Previous horizontal bone augmentation 6 months prior to implant placement

          -  Adequate oral hygiene i.e. Full mouth bleeding score (FMBS) &lt;20% and Full mouth plaque
             score (FMPS) &lt; 20%)

        Exclusion Criteria:

          -  Smokers more than 10 cigarettes/day

          -  Pregnant/lactating women

          -  Alcoholics/drug addicts

          -  Uncontrolled diabetics, immunocompromised, blood hemostasis problems

          -  Patients taking IV bisphosphonates or drugs affecting bone metabolism or mucosal
             healing

          -  Patients not willing to sign the consent form

          -  History of radiotherapy in the head and neck region in the last 5 years

          -  Active periodontitis on the remaining teeth
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nada Naaman, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Saint-Joseph University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Saint-Joseph University</name>
      <address>
        <city>Beirut</city>
        <zip>1104 2020</zip>
        <country>Lebanon</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Lebanon</country>
  </location_countries>
  <reference>
    <citation>Shi JY, Jie-Ni, Zhuang LF, Zhang XM, Fan LF, Lai HC. Peri-implant conditions and marginal bone loss around cemented and screw-retained single implant crowns in posterior regions: A retrospective cohort study with up to 4 years follow-up. PLoS One. 2018 Feb 5;13(2):e0191717. doi: 10.1371/journal.pone.0191717. eCollection 2018.</citation>
    <PMID>29401469</PMID>
  </reference>
  <reference>
    <citation>Liu J, Kerns DG. Mechanisms of guided bone regeneration: a review. Open Dent J. 2014 May 16;8:56-65. doi: 10.2174/1874210601408010056. eCollection 2014.</citation>
    <PMID>24894890</PMID>
  </reference>
  <reference>
    <citation>Koller CD, Pereira-Cenci T, Boscato N. Parameters Associated with Marginal Bone Loss around Implant after Prosthetic Loading. Braz Dent J. 2016 May-Jun;27(3):292-7. doi: 10.1590/0103-6440201600874.</citation>
    <PMID>27224562</PMID>
  </reference>
  <reference>
    <citation>Wennerberg A, Hallgren C, Johansson C, Danelli S. A histomorphometric evaluation of screw-shaped implants each prepared with two surface roughnesses. Clin Oral Implants Res. 1998 Feb;9(1):11-9.</citation>
    <PMID>9590940</PMID>
  </reference>
  <reference>
    <citation>Rosa MB, Albrektsson T, Francischone CE, Schwartz Filho HO, Wennerberg A. The influence of surface treatment on the implant roughness pattern. J Appl Oral Sci. 2012 Sep-Oct;20(5):550-5.</citation>
    <PMID>23138742</PMID>
  </reference>
  <reference>
    <citation>Esposito M, Ardebili Y, Worthington HV. Interventions for replacing missing teeth: different types of dental implants. Cochrane Database Syst Rev. 2014 Jul 22;(7):CD003815. doi: 10.1002/14651858.CD003815.pub4. Review.</citation>
    <PMID>25048469</PMID>
  </reference>
  <reference>
    <citation>Donati M, Ekestubbe A, Lindhe J, Wennström JL. Marginal bone loss at implants with different surface characteristics - A 20-year follow-up of a randomized controlled clinical trial. Clin Oral Implants Res. 2018 May;29(5):480-487. doi: 10.1111/clr.13145. Epub 2018 Mar 23.</citation>
    <PMID>29569767</PMID>
  </reference>
  <reference>
    <citation>Testori T, Wiseman L, Woolfe S, Porter SS. A prospective multicenter clinical study of the Osseotite implant: four-year interim report. Int J Oral Maxillofac Implants. 2001 Mar-Apr;16(2):193-200.</citation>
    <PMID>11324207</PMID>
  </reference>
  <reference>
    <citation>Zetterqvist L, Feldman S, Rotter B, Vincenzi G, Wennström JL, Chierico A, Stach RM, Kenealy JN. A prospective, multicenter, randomized-controlled 5-year study of hybrid and fully etched implants for the incidence of peri-implantitis. J Periodontol. 2010 Apr;81(4):493-501. doi: 10.1902/jop.2009.090492.</citation>
    <PMID>20367092</PMID>
  </reference>
  <reference>
    <citation>Nevins M, Mellonig JT, Clem DS 3rd, Reiser GM, Buser DA. Implants in regenerated bone: long-term survival. Int J Periodontics Restorative Dent. 1998 Feb;18(1):34-45.</citation>
    <PMID>9558555</PMID>
  </reference>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 3, 2020</study_first_submitted>
  <study_first_submitted_qc>April 8, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 13, 2020</study_first_posted>
  <last_update_submitted>April 8, 2020</last_update_submitted>
  <last_update_submitted_qc>April 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Saint-Joseph University</investigator_affiliation>
    <investigator_full_name>Nada BOU ABBOUD NAAMAN</investigator_full_name>
    <investigator_title>Full Professor</investigator_title>
  </responsible_party>
  <keyword>Alveolar ridge augmentation</keyword>
  <keyword>Dental implants</keyword>
  <keyword>Marginal bone remodeling</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>The outcome measurements and patients characteristics might be shared</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>1 year from date of publication</ipd_time_frame>
    <ipd_access_criteria>Following a direct request, for meta-analysis or literature review report.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

